ACADIA Pharmaceuticals

ACADIA Pharmaceuticals

Employees:
400
Market Cap:
$3.87 billion
Revenue:
$17.17 million
5 Year Trend:
53.0%
Net Income:
$-282.79 million
NASDAQ:
ACAD

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

ACADIA Pharmaceuticals
Employees:
400
Market Cap:
$3.87 billion
Revenue:
$17.17 million
5 Year Trend:
53.0%
Net Income:
$-282.79 million
NASDAQ:
ACAD

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

6 jobs at ACADIA Pharmaceuticals

Jobs in